Skip to main content
. 2017 Aug 4;10(5):772–779. doi: 10.1016/j.tranon.2017.07.002

Table 1.

Characteristics of Glioma Patients

Code-Subtype Sex Age WHO Grade Location of Tumor Survival (Months)
Glioblastomas
 003-GB M 67 IV Frontal 49
 022-GB M 75 IV Temporal 11
 027-GB M 67 IV Frontal 35
 038-GB F 68 IV Occipital 23
Oligodendrogliomas
 004-OD M 44 II Frontal A (57)
 008-OD§ F 40 II-III Insula A (56)
 020-OD§ M 69 II-III Frontal A (48)
 014-AOD* M 39 III-IV Temporal 9
Oligoastrocytomas
 036-OA M 70 II Temporal 7
 015-OA§ M 35 II-III Temporal A (51)
 025-OA§ F 31 II-III Frontal A (44)
 039-OA M 51 II-III Frontal A (37)
 002-OA§ M 42 III Parietal 45
 016-OA§ F 27 III Temporal + insula A (51)
 026-OA,§ F 61 III Frontal 23
 034-OA§ M 39 III Frontal A (39)
Ependymomas
 035-E M 76 II 4th ventricle 4

A, alive (in parenthesis months since operation); E, ependymoma; F, female; M, male.

*

Oligodendroglioma 4 and 12 year earlier.

Anaplastic oligodendroglioma 4 years earlier.

Ependymoma 8 years earlier.

§

IDHR132 mutation.